TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

BioXcel Therapeutics, Inc. (NASDAQ: BTAI) Investor Securities Class Action Lawsuit 07/07/2023

  • If you purchased a significant amount of shares of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) between December 15, 2021 and June 28, 2023, and / or if you purchased any NASDAQ: BTAI shares prior to December 2021 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: September 5, 2023. NASDAQ: BTAI investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

December 5, 2023 - An amended complaint was filed. July 07, 2023 - An investor in shares of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) filed a lawsuit in the U.S. District Court for the District of Connecticut over alleged violations of Federal Securities Laws by BioXcel Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between December 15, 20...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)